Thomas E Renau

Title: Thomas E Renau: Innovator in Pharmaceutical Compounds

Introduction

Thomas E Renau is a notable inventor based in San Carlos, CA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific biological mechanisms. With a total of 2 patents, his work has the potential to impact the treatment of various medical conditions.

Latest Patents

Renau's latest patents include innovative compounds that serve as phosphodiesterase 4 inhibitors. These compounds, specifically 4-(substituted-phenyl)-2-pyrrolidinone, demonstrate improved PDE4 inhibition compared to existing compounds like rolipram. They also show selectivity in inhibiting other classes of PDEs. Another significant patent involves fungal efflux pump inhibitors, which are designed to enhance the efficacy of anti-fungal agents against infections caused by fungi that utilize an efflux pump resistance mechanism.

Career Highlights

Throughout his career, Thomas E Renau has worked with several companies, including Essential Therapeutics, Inc. and Memory Pharmaceuticals Corporation. His experience in these organizations has allowed him to refine his expertise in pharmaceutical development and innovation.

Collaborations

Renau has collaborated with notable professionals in the field, including Will J Watkins and Remy Lemoine. These partnerships have contributed to the advancement of his research and the successful development of his patented compounds.

Conclusion

Thomas E Renau's contributions to pharmaceutical innovations highlight his role as a key inventor in the industry. His work on phosphodiesterase 4 inhibitors and fungal efflux pump inhibitors showcases his commitment to advancing medical treatments.